- Adalimumab in a Clinical Practice - Experience with Human Anti TNF-alpha Therapy in Tertiary Clinical CenterPublication without faculty affiliation
- Safety of Anti-TNF-Alpha Therapy During Pregnancy on Longterm Outcome of Exposed Children: A Controlled, Multicenter Observation2019 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNF alpha therapy and discontinuation of glucocorticoids2013 | First Faculty of Medicine
- Immunopathological complications of anti-TNF-alpha biological treatment2016 | First Faculty of Medicine
- Anti-TNF alpha Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure2017 | Second Faculty of Medicine
- ATTRA project of anti TNF alpha blocking therapy in RA. Results of long-term study: efficacy and safetyPublication without faculty affiliation
- Treatment of ANCA positive systemic vasculitis with the anti-TNF alpha2004 | First Faculty of Medicine
- Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study2013 | First Faculty of Medicine, Central Library of Charles University
- The Czech nationwide program for longitudinal monitoring of anti-TNF alpha therapy of rheumatoid arthritis - project ATTRA and its one-year experiencePublication without faculty affiliation
- Formation of antiphospholipid antibodies and antibodies to infliximab in anti-TNF-alpha antibody treated patients with inflammatory bowel diseasesPublication without faculty affiliation
- Neurological and MRI Screening Improves Long-term anti-TNF-alpha Treatment Safety in Patients with Crohn's Disease2017 | Second Faculty of Medicine
- The czech nationwide program for longitudina monitoring of anti-TNF alpha therapy of rheumatoid artritis - projekt attra and its one - year experiencePublication without faculty affiliation
- Are Anti-TNF-alpha Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature2016 | Second Faculty of Medicine
- Impact of Anti-Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children2014 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)Publication without faculty affiliation
- Surgical treatment of Crohn's disease in children in the era of biological treatment2022 | Second Faculty of Medicine
- The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease2020 | Second Faculty of Medicine
- Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Active Rheumatoid Arthritis: The RAPID 2 Study. A Randomized, Controlled Trial.2009 | First Faculty of Medicine
- Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.2009 | First Faculty of Medicine
- Endoscopic Recurrence 6 Months After Ileocecal Resection in Children With Crohn Disease Treated With Azathioprine2017 | Second Faculty of Medicine
- Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort2017 | First Faculty of Medicine
- Crohn's disease: Is there a place for neurological screening?2014 | Second Faculty of Medicine
- Long-term therapy of idiopathic inflammatory bowel disease2012 | First Faculty of Medicine
- Vedolizumab for the treatment of Crohn's disease and ulcerative colitis2015 | First Faculty of Medicine
- Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial2017 | Faculty of Medicine in Hradec Králové
- Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy2022 | Second Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
